Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

[Kidney function tests in multiple sclerosis].
Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals.
2-Deoxy-d-glucose attenuates sevoflurane-induced neuroinflammation through nuclear factor-kappa B pathway in vitro.
[Fingolimod compassionate use program : Case study on the concept of a therapy option for multiple sclerosis prior to marketing approval.]
[Neurodegenerative process in multiple sclerosis and a possible neuroprotective effect of Β-interferon 1a (avonex).]
Editorial comment.
A patient with narcolepsy with cataplexy and multiple sclerosis: two different diseases that may share pathophysiologic mechanisms?
Microsatellite polymorphism in haem oxygenase 1 gene promoter in multiple sclerosis.
A mechanism-based classification of pain in multiple sclerosis.
Epstein-Barr virus infection: A smoking gun for multiple sclerosis?
Sphingosine 1 Phosphate at the Blood Brain Barrier: Can the Modulation of S1P Receptor 1 Influence the Response of Endothelial Cells and Astrocytes to Inflammatory Stimuli?
Antibodies target microvessels in neuromyelitis optica and multiple sclerosis patients.
One step forward in the quest for evidence of the efficacy of cognitive rehabilitation in multiple sclerosis.
[Treatment of relapses of multiple sclerosis (a review)].
Brain stem and cerebellar atrophy in chronic progressive neuro-Behçet's disease.
Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis.
Plasma Exchange Is Effective in a 13-Year-Old Girl with Steroid-Resistant Bilateral Optic Neuritis.
Neuropathic pain in animal models of nervous system autoimmune diseases.
FDA warns about the risks of unproven surgical therapy for multiple sclerosis.
Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils.
Disability progression in relapsing MS is more than just lesions: The lesson of fingolimod.
Evaluation of the Acquisition of the Aerobic Metabolic Capacity by Myelin, during its Development.
Enhanced remyelination following lysolecithin-induced demyelination in mice under treatment with fingolimod (FTY720).
Role of iNOS-NO-cGMP signaling in modulation of inflammatory and myelination processes.
Early netrin-1 expression impairs central nervous system remyelination.

Pages